4//SEC Filing
McNulty Alana B. 4
Accession 0001209191-21-053698
CIK 0001828522other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 6:11 PM ET
Size
25.7 KB
Accession
0001209191-21-053698
Insider Transaction Report
Form 4
McNulty Alana B.
Chief Business Officer
Transactions
- Award
Common Stock
2021-08-25+48,768→ 48,768 total - Award
Stock Option (Right to Buy)
2021-08-25+38,628→ 38,628 totalExercise: $0.73Exp: 2024-12-03→ Common Stock (38,628 underlying) - Award
Stock Option (Right to Buy)
2021-08-25+120,713→ 120,713 totalExercise: $0.94Exp: 2025-10-18→ Common Stock (120,713 underlying) - Award
Stock Option (Right to Buy)
2021-08-25+113,470→ 113,470 totalExercise: $1.14Exp: 2026-01-07→ Common Stock (113,470 underlying) - Award
Stock Option (Right to Buy)
2021-08-25+43,456→ 43,456 totalExercise: $1.14Exp: 2026-02-16→ Common Stock (43,456 underlying) - Award
Stock Option (Right to Buy)
2021-08-25+96,570→ 96,570 totalExercise: $1.35Exp: 2030-04-12→ Common Stock (96,570 underlying) - Award
Stock Option (Right to Buy)
2021-08-25+96,570→ 96,570 totalExercise: $1.66Exp: 2027-08-20→ Common Stock (96,570 underlying) - Award
Stock Option (Right to Buy)
2021-08-25+65,185→ 65,185 totalExercise: $1.35Exp: 2029-06-05→ Common Stock (65,185 underlying) - Award
Earn-out Right
2021-08-25+91,826→ 91,826 total→ Common Stock (91,826 underlying)
Footnotes (10)
- [F1]On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Old eFFECTOR was automatically cancelled and converted into approximately 0.09657 (the "Exchange Ratio") shares of common stock of the Issuer.
- [F10]Each earn-out right represents a contingent right to receive one share of the Issuer's common stock. Pursuant to an "Earn-Out" provision in the Merger Agreement, the earn-out rights vest upon the Issuer's common stock achieving a price per share which equals or exceeds $20.00 over at least 20 trading days out of a 30 consecutive trading day period prior to August 26, 2023.
- [F2]At the Effective Time, each outstanding option to purchase shares of old eFFECTOR common stock (each an "old eFFECTOR Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of old eFFECTOR common stock subject to the applicable old eFFECTOR Option multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share.
- [F3]The stock option vests 25% on December 4, 2015, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- [F4]The stock option vests 25% on October 19, 2016, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- [F5]The stock option vests 25% on January 8, 2017, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- [F6]The stock option vests 25% on February 17, 2017, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- [F7]The stock option vests 25% on August 21, 2018, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- [F8]The stock option vests 25% on June 6, 2020, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- [F9]The stock option vests 25% on April 13, 2021, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001606086
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 6:11 PM ET
- Size
- 25.7 KB